CROI 2016 Program at a Glance

Program and Agenda

Session O-15 Oral Abstracts

Room 311

11:15 169LB Measuring the Impact of Test & Treat on the HIV Cascade: The Challenge of Mobility Joseph Larmarange 1 ; Collins Iwuji 2 ; Joanna Orne-

10:00 AM-12:00 PM Focus on HIV Acquisition and Challenges in the Cascade Oral Abstract Moderators Beatriz Grinsztejn , InstitutodePesquisaClínicaEvandroChagas (IPEC)/ FundaçãoOswaldoCruz (Fiocruz),Riode Janeiro,Brazil Timothy H. Holtz ,Centers forDiseaseControlandPrevention,Atlanta,GA,USA 163 Withdrawn 10:00 164 Isolated Seminal HIV-1 RNA Shedding in African MenWith UninfectedWomen Partners

Gliemann 3 ; Nuala McGrath 4 ; Mélanie Plazy 3 ; Kathy Baisley 5 ; Till Bärnighausen 6 ; Francois Dabis 7 ; Deenan Pillay 8 ; for the ANRS 12249TasP Study Group 1 UniversitéParisDescartes,Paris,France; 2 AfricaCntr for PopulationHlth,Mtubatuba,SouthAfrica; 3 INSERM,Bordeaux, France; 4 UnivofSouthampton,Southampton,UnitedKingdom; 5 LondonSchofHygiene&TropMed,London,UK; 6 Harvard SchofPH,Boston,MA,USA; 7 INSERMU897, ISPED,Univde Bordeaux,Bordeaux,France; 8 AfricaCntr forHlthandPopStudies, Mtubatuba,SouthAfrica

AndrewMujugira 1 ; Connie M. Celum 1 ; Allan Ronald 2 ; Nelly R. Mugo 3 ; RobertW. Coombs 1 ; Jared M. Baeten 1 ; for the Partners PrEP StudyTeam

11:30 169aLB HIV-1 InfectionWith Multiclass Resistance Despite Preexposure Prophylaxis (PrEP) David C. Knox 1 ; Darrell H.Tan 2 ; P. Richard Harrigan 3 ; Peter L. Anderson 4 1 MapleLeafMedClinic,Toronto,ON,Canada; 2 StMichael’s Hosp,Toronto,ON,Canada; 3 BCCntr forExcellence inHIV/AIDS, Vancouver,BC,Canada; 4 UnivofColorado,Denver,CO,USA 11:45 169bLB Gel Applied as Anal LubeWithout Applicator

1 UnivofWashington,Seattle,WA,USA; 2 UnivofManitoba, Winnipeg,MB,Canada; 3 KenyaMedRsr Inst,Thika,Kenya 10:15 165 Exploring the Effectiveness of Traditional Circumcision Practices in Preventing HIV

Michael Pickles 1 ; Anne Cori 1 ; Sian Floyd 2 ; Helen Ayles 2 ; Nulda Beyers 3 ; Peter Bock 4 ; Sarah j. Fidler 1 ; Richard Hayes 2 ; Christophe Fraser 1 ; for the HPTN 071 (PopART) StudyTeam 1 ImperialCollLondon,London,UK; 2 LondonSchofHygiene&Trop Med,London,UK; 3 UnivofStellenbosch,Tygerberg,SouthAfrica; 4 UnivofStellenbosch,CapeTown,SouthAfrica

Provides Poor Rectal Mucosal HIV Coverage Eugenie Shieh 1 ; EthelWeld 1 ; Edward J. Fuchs 1 ; KarenW. Buckheit 2 ; RobertW. Buckheit Jr 2 ; Jennifer Breakey 1 ; Craig Hendrix 1 1 JohnsHopkinsUniv,Baltimore,MD,USA; 2 ImQuestBiosciences, Inc,Frederick,MD,USA

Thursday, February 25, 2016 • Oral Sessions

10:30 166 2013-14 Rwanda HIV Incidence Household Survey: Understanding HIV Epidemic in Rwanda Eric Remera 1 ; Jean Paul Uwizihiwe 1 ; Steve Kanters 2 ; Augustin Mulindabigwi 1 ; Mwumvaneza Mutagoma 1 ; Edward Mills 2 ; Sabin nsanzimana 3 1 InstofHIV/AIDSDiseasePreventionandControl,RwandaBiomed Cntr,Kigali,Rwanda; 2 GlobalEvaluativeScis,Vancouver,BC, Canada; 3 RwandaBiomedCntr,Kigali,Rwanda 10:45 167 Antiretroviral Therapy and HIV Acquisition in a South African Population-Based Cohort 1 HarvardSchofPH,Boston,MA,USA; 2 AfricaCntr forHlthand PopStudies,Mtubatuba,SouthAfrica; 3 BrownUnivSchofPH, Providence,RI,USA; 4 TheFenway Inst,FenwayHlth,Boston,MA, USA 11:00 168LB Option B+ in Malawi: Have 4 Years of“Treat All” Shown That 90-90-90 Is Achievable? BethTippett Barr 1 ; Andreas Jahn 2 ; Sundeep K. Gupta 3 ; Alice Maida 3 ; Frank Chimbwandira 2 1 CDC,Harare,Zimbabwe; 2 MinistryofHlth,Lilongwe,Malawi; 3 CDC,Lilongwe,Malawi Catherine Oldenburg 1 ;Till Bärnighausen 1 ; FrankTanser 2 ; Victor De Gruttola 1 ; George R. Seage 1 ; Matthew Mimiaga 3 ; Kenneth H. Mayer 4 ; Deenan Pillay 2 ; Guy Harling 1

Session TD-13 Themed Discussion

Ballroom B/C

1:45 PM-2:45 PM HIV Effects on Liver Fibrosis and Steatosis Themed Discussion Leader

Kenneth E. Sherman ,UniversityofCincinnati,Cincinnati,OH,USA 558 Poorly Controlled HIV Infection Is a Risk Factor for Liver Fibrosis in CNICS Cohort Nina Kim 1 ; Robin Nance 1 ; StephenVan Rompaey 1 ; Joseph A. Delaney 2 ; Heidi M. Crane 1 ; Katerina A. Christopoulos 3 ;Wm. Christopher Mathews 4 ; Richard Moore 5 ; Mari M. Kitahata 1 ; for the Center for AIDS Research Network of Integrated Clinical Systems 1 UnivofWashington,Seattle,WA,USA; 2 UnivofWashingtonSchofPH andCommunityMed,Seattle,WA,USA; 3 UnivofCaliforniaSanFrancisco, SanFrancisco,CA,USA; 4 UnivofCaliforniaSanDiego,SanDiego,CA,USA; 5 JohnsHopkinsUniv,Baltimore,MD,USA 560 Liver Fibrosis in HIV Patients: Which Factors Play a Role? Raphael Mohr 1 ; Christoph Boesecke 1 ; Carolynne Schwarze-Zander 1 ; Jan-ChristianWasmuth 1 ; Jürgen K. Rockstroh 2 1 UnivHospBonn,Bonn,Germany; 2 MedizinischeUnivsklinik,Bonn, Germany

45

CROI 2016